塞曲司特 T0212
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
200 mg | 112665-43-7 | ¥2,080.00 | 询底价 |
5 mg | 112665-43-7 | ¥255.00 | 询底价 |
1 mL | 112665-43-7 | ¥327.00 | 询底价 |
10 mg | 112665-43-7 | ¥413.00 | 询底价 |
25 mg | 112665-43-7 | ¥637.00 | 询底价 |
50 mg | 112665-43-7 | ¥828.00 | 询底价 |
500 mg | 112665-43-7 | ¥3,530.00 | 询底价 |
100 mg | 112665-43-7 | ¥1,370.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Seratrodast
描述: Seratrodast (ABT-001) 是一种血栓素 A2 受体 (TP) 拮抗剂,用于治疗哮喘。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (141.07 mM)
关键字: Seratrodast | Inhibitor | Prostaglandin Receptor | inhibit | ABT001 | ABT 001 | AA-2414 | AA2414
相关产品: trans-Cinnamaldehyde | Dehydrodiisoeugenol | NS-398 | Cinchophen | Suxibuzone | Macelignan | (-)-Epicatechin | Acetaminophen | Lupeolic acid | Nitroaspirin
相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-Neurodegenerative Disease Compound Library | Transcription Factor-Targeted Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | GPCR Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library
塞曲司特 T0212信息由TargetMol中国为您提供,如您想了解更多关于塞曲司特 T0212报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途